☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Ocular Itching
Ocular Therapeutix Reports sNDA Submission of Dextenza (dexamethasone ophthalmic insert) to the US FDA for Ocular Itching
December 23, 2020
Bausch + Lomb Licenses US Commercial Rights for Eton Pharmaceuticals' EM-100 to Treat Ocular Itching
February 20, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.